Načítá se...
Drug treatment of coronavirus disease 2019 (COVID-19) in China.
Since December 2019, the coronavirus disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has spread throughout China as well as other countries. More than 8,700,000 confirmed COVID-19 cases have been recorded worldwide so far, with much more cases poppi...
Uloženo v:
| Vydáno v: | Eur J Pharmacol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier B.V.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7319927/ https://ncbi.nlm.nih.gov/pubmed/32598953 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejphar.2020.173326 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|